HOME >> MEDICINE >> NEWS
Implantable defibrillators cost-effective for preventing sudden death

collected on a subgroup of 237 patients, who were a balanced representation of the larger trial, geographically and medically.

We called these the shoebox patients, because we told them we wanted all their bills just bring them in a shoebox, says Larsen. The researchers converted the charges to 1997 costs. Three-year survival data from AVID were used to calculate the base cost effectiveness (C/E ratio). Six-year, 20-year and lifetime C/E ratios were also estimated.

The researchers determined that the largest expense for these patients is inpatient care, which makes up between 73 percent of total costs for drug therapy patients and 84 percent for ICD patients. At three years, the cost for the drug treatment group was $71,421. For the defibrillator group it was $85,522. The ICD provided a 0.21-year average survival benefit, putting the cost-effectiveness ratio at $66,677 per year of life saved.

The defibrillator patients lived longer, but they paid extra to get that extra life. The ratio of the additional amount paid for the additional survival benefit is the cost-effectiveness number, Larsen says.

According to Larsen, the conventional wisdom about cost-effectiveness ratios is that something is a bargain below about $50,000 per year of life saved, so the defibrillator is just on the margin of that bargain. Its on the high side but not out of reason.

The researchers also found that six- and 20-year C/E ratios remained stable between $68,000 and $80,000 per year of life saved.

This is only the beginning when it comes to cost-effectiveness studies on the devices, Larsen says. The cost effectiveness issue is going to be a very big part of the defibrillator story during the next year or two as more and more people look to ICDs for treatment.

For example, there may be changes in some of the big expenses from the ICD group, such as how often the ICD battery may need to be replaced, he says. At three
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
15-Apr-2002


Page: 1 2 3

Related medicine news :

1. Implantable heart defibrillators
2. Statement: Implantable medical identification chip
3. Implantable cardiac defibrillator use significantly lowers heart failure mortality
4. Implantable device pumps up ailing heart
5. Implantable heart device reduces deaths by one-third
6. Implanted defibrillators cut heart patients death risk, some more than others
7. Implanted defibrillators not covered for half of patients who could benefit, study finds
8. More doubts over value of defibrillators
9. One use every seven years makes automated external defibrillators a good buy
10. Benefit of public defibrillators is marginal
11. Health and fitness facilities need defibrillators

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... Based on worldwide ... and efficacy of HBOT in treating and helping to heal addictions and substance ... showing the similarities of the wounds to the brain from traumatic brain injuries, ...
(Date:8/23/2017)... ... August 23, 2017 , ... PreCheck, Inc., ... 2017 Inc. 5000 with a three-year sales growth of 49 percent . ... and comprises the most comprehensive look at America’s independent entrepreneurs. This represents PreCheck’s ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... today that has been named to the 2017 Inc. 500|5000, an exclusive ranking ... a three-year growth rate of 139 percent, marking the twelfth year that the ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... American Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical ... pain or injury. According to the report, a wider scope of physical therapy ...
(Date:8/22/2017)... California (PRWEB) , ... August 22, 2017 , ... ... that the key to good health is as simple as eating healthy foods. ... food—whether it be storing fat, making insulin, or breaking apart carbohydrates—depends not only ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Mich. , Aug. 15, 2017 Diplomat ... naloxone to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher ... approved by the Food and Drug Administration, is intended ... extreme drowsiness, slowed breathing, and loss of consciousness. The ...
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... DUBLIN, Aug. 8, 2017   ... $3.12 diluted (GAAP) loss per share from continuing operations ... Products revenues increased 16 percent to $110 million ... increased 27 percent to $161 million ... (EPS) from continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology:
Cached News: